Position in EXEL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$783,340
+$150,541 QoQ
Shares Held
14,397
-2.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#367
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Values First Advisors, Inc. holds $10,629,094 across 12 Biotechnology names. EXEL ranks #8 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
40,301 | $2,847,264 | |
| 2 | RPRX |
Royalty Pharma plc
|
21,005 | $1,177,750 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
9,479 | $1,109,706 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
19,463 | $1,070,465 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,178 | $956,673 | |
| 6 | ARGX |
Argenx SE
|
999 | $926,842 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
3,320 | $812,636 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
14,397 | $783,340 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $783,340 | 14,397 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $632,799 | 14,754 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $643,117 | 14,673 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $731,423 | 17,710 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $795,599 | 18,049 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $665,039 | 18,013 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $603,895 | 18,135 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $464,297 | 17,892 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $408,055 | 18,160 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $431,886 | 18,200 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $408,597 | 17,032 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $345,776 | 15,825 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $304,594 | 15,939 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $302,582 | 15,589 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $242,925 | 15,145 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $239,167 | 15,253 | Shares | Sole | 2022-12-02 | |
| 2022-06-30 | $307,303 | 14,760 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $357,256 | 15,759 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $263,561 | 14,418 | Shares | Sole | 2022-03-10 | |
| 2021-09-30 | $334,815 | 15,838 | Shares | Sole | 2022-11-15 | |
| 2021-06-30 | $279,148 | 15,321 | Shares | Sole | 2022-11-15 | |
| 2021-03-31 | $353,352 | 15,642 | Shares | Sole | 2022-11-15 | |
| 2020-12-31 | $306,569 | 15,275 | Shares | Sole | 2022-11-15 | |
| 2020-09-30 | $388,877 | 15,905 | Shares | Sole | 2022-11-15 | |
| 2020-06-30 | $357,975 | 15,079 | Shares | Sole | 2022-11-15 | |
| 2020-03-31 | $265,756 | 15,433 | Shares | Sole | 2023-01-09 | |
| No filing history on record for this holder in this stock. | ||||||